{"doi":"10.3390/ijms25115703","title":"Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease","abstract":"<jats:p>This study investigated the diagnostic accuracy of plasma biomarkers—specifically, matrix metalloproteinase (MMP-9), tissue inhibitor of metalloproteinase (TIMP-1), CD147, and the MMP-/TIMP-1 ratio in patients with Alzheimer’s disease (AD) dementia. The research cohort comprised patients diagnosed with probable AD dementia and a control group of cognitively unimpaired (CU) individuals. Neuroradiological assessments included brain magnetic resonance imaging (MRI) following dementia protocols, with subsequent volumetric analysis. Additionally, cerebrospinal fluid (CSF) AD biomarkers were classified using the A/T/N system, and apolipoprotein E (APOE) ε4 carrier status was determined. Findings revealed elevated plasma levels of MMP-9 and TIMP-1 in AD dementia patients compared to CU individuals. Receiver operating characteristic (ROC) curve analysis demonstrated significant differences in the areas under the curve (AUC) for MMP-9 (p &lt; 0.001) and TIMP-1 (p &lt; 0.001). Notably, plasma TIMP-1 levels were significantly lower in APOE ε4+ patients than in APOE ε4− patients (p = 0.041). Furthermore, APOE ε4+ patients exhibited reduced hippocampal volume, particularly in total, right, and left hippocampal measurements. TIMP-1 levels exhibited a positive correlation, while the MMP-9/TIMP-1 ratio showed a negative correlation with hippocampal volume parameters. This study sheds light on the potential use of TIMP-1 as a diagnostic marker and its association with hippocampal changes in AD.</jats:p>","journal":"International Journal of Molecular Sciences","year":2024,"id":642838,"datarank":0.37273599746820013,"base_score":2.4849066497880004,"endowment":2.4849066497880004,"self_citation_contribution":0.37273599746820013,"citation_network_contribution":0.0,"self_endowment_contribution":0.37273599746820013,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":11,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_data_producer":false,"deposit_databanks":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":494824,"name":"Vuk Milošević","orcid":"0000-0002-2434-8277","position":1,"is_corresponding":false},{"id":1672311,"name":"Branka Djordjević","orcid":null,"position":2,"is_corresponding":false},{"id":1672312,"name":"Vladana Stojiljković","orcid":"0000-0002-2862-5665","position":3,"is_corresponding":false},{"id":1672313,"name":"Milica Živanović","orcid":"0000-0003-1988-7249","position":4,"is_corresponding":false},{"id":1672314,"name":"Nikola Stefanović","orcid":null,"position":5,"is_corresponding":false},{"id":1672315,"name":"Aleksandra Aracki Trenkić","orcid":null,"position":6,"is_corresponding":false},{"id":1672316,"name":"Dragan Stojanov","orcid":null,"position":7,"is_corresponding":false},{"id":1672317,"name":"Tatjana Jevtović Stoimenov","orcid":null,"position":8,"is_corresponding":false},{"id":1672318,"name":"Ivana Stojanović","orcid":null,"position":9,"is_corresponding":false},{"id":1672310,"name":"Jelena Bašić","orcid":"0000-0002-9221-561X","position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"resolved":true,"title":"Matrix Remodeling Enzymes as Potential Fluid Biomarkers of Neurodegeneration in Alzheimer’s Disease","abstract":"<jats:p>This study investigated the diagnostic accuracy of plasma biomarkers—specifically, matrix metalloproteinase (MMP-9), tissue inhibitor of metalloproteinase (TIMP-1), CD147, and the MMP-/TIMP-1 ratio in patients with Alzheimer’s disease (AD) dementia. The research cohort comprised patients diagnosed with probable AD dementia and a control group of cognitively unimpaired (CU) individuals. Neuroradiological assessments included brain magnetic resonance imaging (MRI) following dementia protocols, with subsequent volumetric analysis. Additionally, cerebrospinal fluid (CSF) AD biomarkers were classified using the A/T/N system, and apolipoprotein E (APOE) ε4 carrier status was determined. Findings revealed elevated plasma levels of MMP-9 and TIMP-1 in AD dementia patients compared to CU individuals. Receiver operating characteristic (ROC) curve analysis demonstrated significant differences in the areas under the curve (AUC) for MMP-9 (p &lt; 0.001) and TIMP-1 (p &lt; 0.001). Notably, plasma TIMP-1 levels were significantly lower in APOE ε4+ patients than in APOE ε4− patients (p = 0.041). Furthermore, APOE ε4+ patients exhibited reduced hippocampal volume, particularly in total, right, and left hippocampal measurements. TIMP-1 levels exhibited a positive correlation, while the MMP-9/TIMP-1 ratio showed a negative correlation with hippocampal volume parameters. This study sheds light on the potential use of TIMP-1 as a diagnostic marker and its association with hippocampal changes in AD.</jats:p>","is_dataset_classified":null,"base_score":2.4849066497880004,"endowment":2.4849066497880004,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"38891891","pmcid":"PMC11171655","openalex_id":"https://openalex.org/W4398782709","authors":[],"funders":[{"funder_name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","grant_id":"451-03-65/2024-03/200113","title":null},{"funder_name":"Ministry of Science, Technological Development and Innovation of the Republic of Serbia","grant_id":"INT-MFN-44","title":null},{"funder_name":"Ministry of Education, Science and Technological Development of Republic of Serbia","grant_id":"200113","title":"Ministry of Education, Science and Technological Development, Republic of Serbia, Grant no. 451-03-68/2020-14/200113 (Univeristy of Niö, Faculty of Medicine)"}],"total_grants":3,"fwci":2.6934,"citation_percentile":0.9076216,"influential_citations":0,"citation_trend":[{"year":2025,"count":8},{"year":2026,"count":3}],"oa_status":"gold","license":"cc-by","oa_locations":[{"url":"https://www.mdpi.com/1422-0067/25/11/5703/pdf?version=1716532220","host_type":"journal"},{"url":"https://www.mdpi.com/1422-0067/25/11/5703/pdf?version=1716532220","host_type":"publisher"},{"url":"https://www.mdpi.com/1422-0067/25/11/5703/pdf","host_type":"publisher"},{"url":"https://doi.org/10.3390/ijms25115703","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/38891891","host_type":"repository"},{"url":"https://www.ncbi.nlm.nih.gov/pmc/articles/11171655","host_type":"repository"},{"url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC11171655/pdf/ijms-25-05703.pdf","host_type":"repository"},{"url":"https://europepmc.org/articles/PMC11171655","host_type":"Europe_PMC"},{"url":"https://europepmc.org/articles/PMC11171655?pdf=render","host_type":"Europe_PMC"},{"url":"http://dx.doi.org/10.3390/ijms25115703","host_type":""},{"url":"https://dx.doi.org/10.3390/ijms25115703","host_type":""}],"fields_of_study":["Alzheimer's disease research and treatments","Biochemical effects in animals","Diet and metabolism studies","0301 basic medicine","03 medical and health sciences","0302 clinical medicine","Humans","Alzheimer Disease","Male","Biomarkers","Female","Tissue Inhibitor of Metalloproteinase-1","Aged","Matrix Metalloproteinase 9","Magnetic Resonance Imaging","Middle Aged","Apolipoprotein E4","Hippocampus","Aged, 80 and over","ROC Curve"],"mesh_terms":["Aged","Aged, 80 and over","Alzheimer Disease","Female","Hippocampus","Humans","Magnetic Resonance Imaging","Male","Middle Aged","ROC Curve","Biomarkers","Tissue Inhibitor of Metalloproteinase-1","Matrix Metalloproteinase 9","Apolipoprotein E4"],"keywords":["Neurodegeneration","Disease","Alzheimer's disease","Medicine","Neuroscience","Biology","Pathology","Alzheimer’s disease","tissue inhibitor of metalloproteinase-1","Matrix Metalloproteinase-9","Hippocampal Volume","Apoe Ε4","Male","Aged, 80 and over","Apolipoprotein E4","Middle Aged","Magnetic Resonance Imaging","Hippocampus","Article","Matrix Metalloproteinase 9","ROC Curve","Alzheimer Disease","Humans","Female","Biomarkers","Aged"],"sdg_mappings":[{"sdg_number":3,"sdg_label":"3. Good health"},{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-08-08T04:27:46.979083Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}